- Home
- MPU vs ATYR Comparison
MPU vs ATYR Comparison
Compare MPU & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- ATYR
- Stock Information
- Founded
- MPU 1989
- ATYR 2005
- Country
- MPU Singapore
- ATYR United States
- Employees
- MPU N/A
- ATYR N/A
- Industry
- MPU Transportation Services
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPU Consumer Discretionary
- ATYR Health Care
- Exchange
- MPU Nasdaq
- ATYR Nasdaq
- Market Cap
- MPU 88.9M
- ATYR 77.1M
- IPO Year
- MPU 1998
- ATYR 2015
- Fundamental
- Price
- MPU $0.91
- ATYR $0.68
- Analyst Decision
- MPU
- ATYR Buy
- Analyst Count
- MPU 0
- ATYR 6
- Target Price
- MPU N/A
- ATYR $8.75
- AVG Volume (30 Days)
- MPU 99.9K
- ATYR 4.1M
- Earning Date
- MPU 11-12-2025
- ATYR 11-06-2025
- Dividend Yield
- MPU N/A
- ATYR N/A
- EPS Growth
- MPU N/A
- ATYR N/A
- EPS
- MPU N/A
- ATYR N/A
- Revenue
- MPU $35,373,100.00
- ATYR $190,000.00
- Revenue This Year
- MPU N/A
- ATYR $420.85
- Revenue Next Year
- MPU N/A
- ATYR $1,513.40
- P/E Ratio
- MPU N/A
- ATYR N/A
- Revenue Growth
- MPU 126.64
- ATYR N/A
- 52 Week Low
- MPU $0.49
- ATYR $0.68
- 52 Week High
- MPU $4.44
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- MPU 33.01
- ATYR 26.63
- Support Level
- MPU $0.96
- ATYR $0.74
- Resistance Level
- MPU $1.03
- ATYR $0.81
- Average True Range (ATR)
- MPU 0.09
- ATYR 0.06
- MACD
- MPU 0.00
- ATYR 0.04
- Stochastic Oscillator
- MPU 0.06
- ATYR 1.30
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.